This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (143)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Rick A. Bright, PhD; David K. Shay, MD, MPH; Bo Shu, MD; Nancy J. Cox, PhD; Alexander I. Klimov, PhD

JAMA. 2006;295:891-894. Published online February 2, 2006 (doi:10.1001/jama.295.8.joc60020).

Context  The adamantanes, amantadine and rimantadine, have been used as first-choice antiviral drugs against community outbreaks of influenza A viruses for many years. Rates of viruses resistant to these drugs have been increasing globally. Rapid surveillance for the emergence and spread of resistant viruses has become critical for appropriate treatment of patients.

Objective  To investigate the frequency of adamantane-resistant influenza A viruses circulating in the United States during the initial months of the 2005-2006 influenza season.

Design and Setting  Influenza isolates collected from 26 states from October 1 through December 31, 2005, and submitted to the US Centers for Disease Control and Prevention were tested for drug resistance as part of ongoing surveillance. Isolates were submitted from World Health Organization collaborating laboratories and National Respiratory and Enteric Virus Surveillance System laboratories.

Main Outcome Measures  Using pyrosequencing and confirmatory assays, we identified viruses containing mutations within the M2 gene that are known to confer resistance to both amantadine and rimantadine.

Results  A total of 209 influenza A(H3N2) viruses isolated from patients in 26 states were screened, of which 193 (92.3%) contained a change at amino acid 31 (serine to asparagine [S31N]) in the M2 gene known to be correlated with adamantane resistance. Two of 8 influenza A(H1N1) viruses contained the same mutation. Drug-resistant viruses were distributed across the United States.

Conclusions  The high proportion of influenza A viruses currently circulating in the United States demonstrating adamantane resistance highlights the clinical importance of rapid surveillance for antiviral resistance. Our results indicate that these drugs should not be used for the treatment or prophylaxis of influenza in the United States until susceptibility to adamantanes has been reestablished among circulating influenza A isolates.

Author Affiliations: Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, Ga. As of February 1, 2006, Dr Bright is with Novavax, Malvern, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Shift Shown in Influenza A Adamantane Resistance
Katherine M. Shea
JAMA. 2006;296(13):1585.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance
Raj C. Shah
JAMA. 2006;296(13):1585-1586.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David K. Shay, Rick A. Bright, Michael Shaw, Nancy J. Cox, and Alexander I. Klimov
JAMA. 2006;296(13):1586-1587.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David M. Weinstock and Gianna Zucotti
JAMA. 2006;296(13):1587.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Adamantane Resistance in Influenza A
David M. Weinstock and Gianna Zuccotti
JAMA. 2006;295(8):934-936.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
Shih et al.
J Antimicrob Chemother 2009;0:dkp393v2-dkp393.
ABSTRACT | FULL TEXT  

Unifying Vertical and Nonvertical Evolution: A Stochastic ARG-based Framework
Bloomquist and Suchard
Syst Biol 2009;0:syp076v1-syp076.
ABSTRACT | FULL TEXT  

Changes in Prescribing of Antiviral Medications for Influenza Associated With New Treatment Guidelines
Hersh et al.
AJPH 2009;99:S362-S364.
ABSTRACT | FULL TEXT  

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy
Ludwig
J Antimicrob Chemother 2009;64:1-4.
ABSTRACT | FULL TEXT  

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System
McSharry et al.
Antimicrob. Agents Chemother. 2009;53:2375-2381.
ABSTRACT | FULL TEXT  

Mechanism of drug inhibition and drug resistance of influenza A M2 channel
Pielak et al.
Proc. Natl. Acad. Sci. USA 2009;106:7379-7384.
ABSTRACT | FULL TEXT  

Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert et al.
Science 2009;324:246-251.
ABSTRACT | FULL TEXT  

Universal Detection and Identification of Avian Influenza Virus by Use of Resequencing Microarrays
Lin et al.
J. Clin. Microbiol. 2009;47:988-993.
ABSTRACT | FULL TEXT  

Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 Infection
Prabhu et al.
J. Virol. 2009;83:2553-2562.
ABSTRACT | FULL TEXT  

Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan et al.
JAMA 2009;301:1034-1041.
ABSTRACT | FULL TEXT  

The Evolution of Influenza Resistance and Treatment
Weinstock and Zuccotti
JAMA 2009;301:1066-1069.
FULL TEXT  

Epidemiologic Study of Influenza Infection in Okinawa, Japan, from 2001 to 2007: Changing Patterns of Seasonality and Prevalence of Amantadine-Resistant Influenza A Virus
Suzuki et al.
J. Clin. Microbiol. 2009;47:623-629.
ABSTRACT | FULL TEXT  

Detection of Molecular Markers of Antiviral Resistance in Influenza A (H5N1) Viruses Using a Pyrosequencing Method
Deyde et al.
Antimicrob. Agents Chemother. 2009;53:1039-1047.
ABSTRACT | FULL TEXT  

A humanized anti-M2 scFv shows protective in vitro activity against influenza
Gabbard et al.
Protein Eng Des Sel 2009;22:189-198.
ABSTRACT | FULL TEXT  

CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
Yamashita et al.
Antimicrob. Agents Chemother. 2009;53:186-192.
ABSTRACT | FULL TEXT  

Emergence of Amantadine-Resistant H3N2 Avian Influenza A Virus in South Korea
Lee et al.
J. Clin. Microbiol. 2008;46:3788-3790.
ABSTRACT | FULL TEXT  

High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2)
Severson et al.
J Biomol Screen 2008;13:879-887.
ABSTRACT  

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008
Sheu et al.
Antimicrob. Agents Chemother. 2008;52:3284-3292.
ABSTRACT | FULL TEXT  

Genetic Analysis of Influenza A/H3N2 and A/H1N1 Viruses Circulating in Vietnam from 2001 to 2006
Li et al.
J. Clin. Microbiol. 2008;46:399-405.
ABSTRACT | FULL TEXT  

The effect of population structure on the emergence of drug resistance during influenza pandemics
Debarre et al.
J R Soc Interface 2007;4:893-906.
ABSTRACT | FULL TEXT  

The Genesis and Spread of Reassortment Human Influenza A/H3N2 Viruses Conferring Adamantane Resistance
Simonsen et al.
Mol Biol Evol 2007;24:1811-1820.
ABSTRACT | FULL TEXT  

Avian Influenza Virus (H5N1): a Threat to Human Health
Peiris et al.
Clin. Microbiol. Rev. 2007;20:243-267.
ABSTRACT | FULL TEXT  

Antiviral Therapy and Prophylaxis for Influenza in Children
Committee on Infectious Diseases
Pediatrics 2007;119:852-860.
ABSTRACT | FULL TEXT  

Amantadine-Resistant Influenza A (H3N2) Virus in Japan, 2005-2006
Saito et al.
NEJM 2007;356:312-313.
FULL TEXT  

Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Viral Attachment to Cells
Jones et al.
J. Virol. 2006;80:11960-11967.
ABSTRACT | FULL TEXT  

Update: Influenza Activity--United States and Worldwide, May 21-September 9, 2006
JAMA 2006;296:2549-2550.
FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance
Shea
JAMA 2006;296:1585-1585.
FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance
Shah
JAMA 2006;296:1585-1586.
FULL TEXT  

Longitudinal analysis of genotype distribution of influenza a virus from 2003 to 2005.
Mak et al.
J. Clin. Microbiol. 2006;44:3583-3588.
ABSTRACT | FULL TEXT  

High Adamantane Resistance in Influenza A Isolates
JWatch Emergency Med. 2006;2006:20-20.
FULL TEXT  

Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes and Bonhoeffer
Science 2006;312:389-391.
ABSTRACT | FULL TEXT  

Influenza A Resistance to Adamantanes
JWatch Gastroenterology 2006;2006:11-11.
FULL TEXT  

What's new in the other general journals.
Tonks
BMJ 2006;332:536-537.
FULL TEXT  

Influenza A Resistance to Adamantane
JWatch General 2006;2006:5-5.
FULL TEXT  

Adamantane Resistance in Influenza A
Weinstock and Zuccotti
JAMA 2006;295:934-936.
FULL TEXT